Fig. 7
From: Inhibition of PKA/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer
Clinical significance of CREB1 in NSCLC patients. A The mRNA expression of CREB1 in NSCLC tumor and adjacent normal tissue from TCGA database. B The Kaplan–Meier survival analysis of LUAD and LUSC patients divided by CREB1 expression. C, D Representative images of immunohistochemistry staining of 120 LUAD (C) and 78 LUSC (D) patient samples. E, F The numbers of LUAD (E) and LUSC (F) cases stratified by CREB1 expression. G, H Univariate and multivariate Cox regression analyses for OS of LUAD (G) and LUSC (H) patients. I, J Kaplan–Meier survival analysis with log-rank test demonstrated the OS and RFS in LUAD (I) and LUSC (J) patients with high or low CREB1 expression. OS, overall survival; RFS, recurrence-free survival